2016 editions
- December 2016
Joao Incio on mechanisms to explain why obesity promotes cancer. - November 2016
Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer. - October 2016
Ruth Muschel on a new target for treatments for colorectal cancer. - September 2016
Freddie Hamdy on the effectiveness of treatments for prostate cancer. - August 2016
Moshe Oren discusses the effects of the microenvironment on cancer cells. - July 2016
Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer. - June 2016
Key advances in clinical trials. - May 2016
Mark Lemmon on the underlying biochemistry of cancer. - April 2016
Roger Stupp on using alternating electric fields as treatment. - March 2016
Charlotte Vrinten on public perception of deaths from cancer. - February 2016
Guillermo Garcia-Manero on myelodysplastic syndromes (MDS). - December 2015/January 2016
Nazneen Rahman on germline genetic screening in ovarian cancer.
EJC News Focus – September 2014
What's next for survivors?
Continual improvements in the diagnosis, treatment and care of people with cancer mean increasing numbers of survivors – it's estimated there will be 30 million cancer survivors in the US alone by 2025. While this is obviously good news, many of these people are living with long term medical or psycho-social issues and are in need of specific types of care.
In this month's EJC News Focus, Richard Schilsky, Rob Pieters, Kathy Pritchard, Roger Stupp and Jean-Charles Soria outline the growing issue of survivorship. These experts discuss with Helen Saul the problems that many survivors face. How far do our stretched healthcare systems meet the needs of ever increasing numbers of survivors, and what changes are needed for the future?